166 related articles for article (PubMed ID: 9747435)
1. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia.
Weinbrenner C; Liu GS; Downey JM; Cohen MV
Cardiovasc Res; 1998 Jun; 38(3):676-84. PubMed ID: 9747435
[TBL] [Abstract][Full Text] [Related]
2. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia.
Weinbrenner C; Baines CP; Liu GS; Armstrong SC; Ganote CE; Walsh AH; Honkanen RE; Cohen MV; Downey JM
Circulation; 1998 Sep; 98(9):899-905. PubMed ID: 9738645
[TBL] [Abstract][Full Text] [Related]
3. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning.
Nakano A; Liu GS; Heusch G; Downey JM; Cohen MV
J Mol Cell Cardiol; 2000 Jul; 32(7):1159-67. PubMed ID: 10860760
[TBL] [Abstract][Full Text] [Related]
4. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of protection from 5 (N-ethyl-N-isopropyl)amiloride differs from that of ischemic preconditioning in rabbit heart.
Sato H; Miki T; Vallabhapurapu RP; Wang P; Liu GS; Cohen MV; Downey JM
Basic Res Cardiol; 1997 Oct; 92(5):339-50. PubMed ID: 9486355
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
Woolfson RG; Patel VC; Neild GH; Yellon DM
Circulation; 1995 Mar; 91(5):1545-51. PubMed ID: 7867197
[TBL] [Abstract][Full Text] [Related]
7. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction?
Miki T; Liu GS; Cohen MV; Downey JM
Basic Res Cardiol; 1998 Oct; 93(5):372-83. PubMed ID: 9833149
[TBL] [Abstract][Full Text] [Related]
8. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts.
Okawa H; Horimoto H; Mieno S; Nomura Y; Yoshida M; Shinjiro S
Mol Cell Biochem; 2003 Jun; 248(1-2):171-7. PubMed ID: 12870670
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
10. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.
Yang XM; Proctor JB; Cui L; Krieg T; Downey JM; Cohen MV
J Am Coll Cardiol; 2004 Sep; 44(5):1103-10. PubMed ID: 15337225
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
Beresewicz A; Czarnowska E; Maczewski M
Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
14. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.
Wang P; Downey JM; Cohen MV
Basic Res Cardiol; 1996; 91(6):458-67. PubMed ID: 8996631
[TBL] [Abstract][Full Text] [Related]
15. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator.
Liu Y; Yang XM; Iliodromitis EK; Kremastinos DT; Dost T; Cohen MV; Downey JM
Basic Res Cardiol; 2008 Jan; 103(1):54-9. PubMed ID: 17999029
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
Horimoto H; Saltman AE; Gaudette GR; Krukenkamp IB
Ann Thorac Surg; 1999 Sep; 68(3):844-9. PubMed ID: 10509972
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.
Kawabata H; Ishikawa K
Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407
[TBL] [Abstract][Full Text] [Related]
18. The role of nitric oxide, K(+)(ATP) channels, and cGMP in the preconditioning response of the rabbit.
Horimoto H; Gaudette GR; Saltman AE; Krukenkamp IB
J Surg Res; 2000 Jul; 92(1):56-63. PubMed ID: 10864483
[TBL] [Abstract][Full Text] [Related]
19. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
Nakano A; Cohen MV; Critz S; Downey JM
Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
